- Development of new gene editing delivery systems that cross the blood brain barrier for the treatment of Krabbe Disease and other lysosomal storage disorders. March 2025-March 2027, Fondazione Telethon (Coordinator: A. Cavazza)
- Enhancing the engraftment of ex vivo genetically manipulated hematopoietic stem cells for the treatment of blood disorders (EnGraft). February 2026-February 2029. Fondo Italiano per la Scienza (FIS) Consolidator Grant. (Coordinator: A. Cavazza)
